Sport Medice Industry : Introductions,Models and Market

Introduction :

No matter how many precautions a sport person take and how much he thinks it won't happen to him but injuries are bound happen to sportsman or an athlete. As athletes have to perform on field they have to go through stress, pressure, etc. along with this they have to battle against heat, wind, collisions.  The human body no longer take such stress of that force and he became ill. If the athlete is injured or sick he may not able to compete.  And if the sickness stays for long time then it may harm his performance and might be his career. To prevent this a special field in medical diagnostics is Sport medicine is a branch of medicine which deals with physical fitness, treatment and prevention of injuries related to sports.

Most Common Sport injuries : 

1. Ankle sprain
2. ACL Sprains
3. Muscle Cramps
4. Concussion
5. Shin Splints
6. Muscle Strains

Approach of sports medicine treatment :

1. Industrial athlete : In this approach overall study of an athlete has been done such as monitoring their hearts and lungs, strength/endurance, analyzing their diets and supplements they are taking. That means an ample amount of money had been spent to discover athletes strong and weak zones. Which help them to perform better and overcome sickness as possible as it could be.
2.  Fast and effective return to participation : A typical athlete wants to get back to the game as soon as possible. They don't want to be in bed for 3 weeks or so. That's where the information of individuals is come into the picture and doctors can focus on problems and recover it as soon as possible.
3. Self motivation : in the injury period athlete must not give up his self esteem because self esteem is the biggest part for fast recovery. so we have to maintain a positive and motivated atmosphere in such time.

Sport Medicine Model :

There are two main points of this model. First this model mainly focus on prevention , the athletic trainers work with their athletes so that they can prevent them form injuries.
Second point is when injury does occur the trainers quickly evaluates the severity of the injury and find outs the root cause is the most integral part of prevention plan. Along with the first aide that might be required the trainer assesses the scope of the injury. If the injury falls within scope of practice the trainer plans and implements quick  re-habitation program.

Important Organizations :

1. American College of Sports Medicine (ACSM) 
2. American Orthopaedic Society for Sports Medicine (AOSSM)
3. Canadian Academy of Sport and Exercise Medicine
4. American Medical Society for Sports Medicine (AMSSM)
5. National Athletic Trainers' Association(NATA)
6. Canadian Athletic Therapists' Association(CATA) 
7. American Medical Association(AMA)

Sport Medicine Market :

Sport medicine market includes the products and devices that are used by athletes to prevent and protect them from injuries.this market party include the orthopedics market as large sport injuries involves orthopedic implants.it comprises of various products such as ice packs,hot packs,topical pain relief products,compression clothing,etc

For Details On Market : Click Here

Introduction To Machine To Machine Market

Introduction To M2M Market :

Machine to machine (M2M) uses a devices such as a sensors or meters to capture an event such as temperature, inventory level, that is received and passed through a network such as wireless, wired or hybrid to a software program that translates the captured event into meaningful information.

In product restocking, for example, when a particular item is running low a vending machine can message the distributor. M2M communication is an important aspect of warehouse management, logistic services, supply chain management, fleet management and telemedicine,remote control, robotics, traffic control.  It forms the basis for a concept known as the Internet of Things.

Key components of an M2M system include sensors, RFID, a Wi-Fi or cellular communications link and autonomic computing software programmed to help a networked device interpret data and make decisions. The most well-known type of M2M communication is telemetry, which has been used since the early part of the last century to transmit operational data. Pioneers in telemetrics first used telephone lines -- and later, on radio waves -- to transmit performance measurements gathered from monitoring instruments in remote locations. The Internet and improved standards for wireless technology have expanded the role of telemetry from pure science, engineering and manufacturing to everyday use in products like home heating units, electric meters and Internet-connected appliances. Products built with M2M communication capabilities are often marketed to end users as being “smart.”

Currently, M2M does not have a standardized connected device platform and many M2M systems are built to be task- or device-specific. It is expected that as M2M becomes more pervasive, vendors will need to agree upon standards for device-to-device communications.

 

Market Of M2M Industry :

The global Machine To Machine market is expected to grow from $21.52 billion in 2011 to $85.96 billion in 2017 at a CAGR of 26.1% from 2012 to 2017.

Source :  Markets And Markets

The industry players present along the value chain are involved in initiatives such as alliances, partnerships, and joint ventures to achieve better market recognition and facilitate mobile operators to work directly with companies selling Machine to machine services. Some of the key players involved in the design, development, and supply of M2M solutions include Sierra Wireless (U.S.), Jasper Wireless (U.S.), Telit Communications (Italy), Numerex Corp (U.S.), NTT DoCoMo (Japan), and more.

FOR More Details : Click Here

Introduction to Anesthesia And Anesthesia Drugs Market by 2015

History of Anesthesia :

• William Morton, dentist – first demonstration of successful surgical anesthesia with ether 1846.
• John C. Warren, surgeon at MGH says “Gentlemen, this is no humbug!” – birth of modern anesthesia.
• Dr. John Snow administers chloroform to Queen Victoria (1853)– popularizes anesthesia for childbirth in UK.
• He becomes the first anesthesia specialist.

Note that ether became anesthesia of choice in US, chloroform in UK.

Introduction To Anesthesia :

• Allow surgical, obstetrical and diagnostic procedures to be performed in a manner which is painless to the patient
• Allow control of factors such as physiologic functions and patient movement

 What is “Anesthesia" ...? 

• No universally accepted definition
    
• Usually thought to consist of:
                  1.Oblivion
                  2.Amnesia
                  3.Analgesia
                  4.Lack of Movement
                  5.Hemodynamic Stability
   
• Sensory
  • Absence of intraoperative pain
   
• Cognitive:
  • Absence of intraoperative awareness
  • Absence of recall of intraoperative events

• Motor:
  • Absence of movement
  • Adequate muscular relaxation
   
• Autonomic:
  • Absence of hydrodynamic response 
  • Absence of tearing, flushing, sweating

Anesthetic Techniques :

• General anesthesia
• Regional anesthesia
• Local anesthesia
• Conscious Sedation (monitored anesthesia care)

Goals of General Anesthesia :

• Hypnosis (unconsciousness)
• Amnesia
• Analgesia
• Immobility/decreased muscle tone (relaxation of skeletal muscle)
• Inhibition of nociceptive reflexes
• Reduction of certain autonomic reflexes (gag reflex, tachycardia, vasoconstriction)

Steps of Anesthesia :

1. Induction : The period of time from the onset of administration of the anesthetic to    the development of effective surgical anesthesia in the patient.
2. Maintenance : A sustained surgical anesthesia
3. Recovery : Time from discontinuation of administration of the anesthesia until consciousness and protective physiologic reflexes are regained.

Desired Effects Of General Anesthesia  (Balanced Anesthesia) :

• Rapid induction 
• Sleep
• Analgesia
• Secretion control
• Muscle relaxation 
• Rapid reversal

Anesthesia Drugs Market :

The anesthesia drugs market research specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol dis odium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015.

Intravenous anesthetic drugs accounted for the largest share –65% – of the U.S. general anesthetics drugs market in 2011.

Major players such as Abbott laboratories (U.S.), Astrazeneca Plc. (U.K.), Baxter International Inc. (U.S.), Bedford Laboratories (U.S.), Bioniche Pharmaceuticals (U.S.), Eisai Co. Ltd. (Japan), Hospira Inc. (U.S.) and JHP Pharmaceuticals (U.S.).

For Detail Report : Click Here

Anesthesia Industry In Near Future

History of Anesthesia :

• William Morton, dentist – first demonstration of successful surgical anesthesia with ether 1846.
• John C. Warren, surgeon at MGH says “Gentlemen, this is no humbug!” – birth of modern anesthesia.
• Dr. John Snow administers chloroform to Queen Victoria (1853)– popularizes anesthesia for childbirth in UK.
• He becomes the first anesthesia specialist.

Note that ether became anesthesia of choice in US, chloroform in UK.

Introduction To Anesthesia :

• Allow surgical, obstetrical and diagnostic procedures to be performed in a manner which is painless to the patient
• Allow control of factors such as physiologic functions and patient movement

 What is “Anesthesia" ...? 

• No universally accepted definition
    
• Usually thought to consist of:
                  1.Oblivion
                  2.Amnesia
                  3.Analgesia
                  4.Lack of Movement
                  5.Hemodynamic Stability
   
• Sensory
  • Absence of intraoperative pain
   
• Cognitive:
  • Absence of intraoperative awareness
  • Absence of recall of intraoperative events

• Motor:
  • Absence of movement
  • Adequate muscular relaxation
   
• Autonomic:
  • Absence of hydrodynamic response 
  • Absence of tearing, flushing, sweating

Anesthetic Techniques :

• General anesthesia
• Regional anesthesia
• Local anesthesia
• Conscious Sedation (monitored anesthesia care)

Goals of General Anesthesia :

• Hypnosis (unconsciousness)
• Amnesia
• Analgesia
• Immobility/decreased muscle tone (relaxation of skeletal muscle)
• Inhibition of nociceptive reflexes
• Reduction of certain autonomic reflexes (gag reflex, tachycardia, vasoconstriction)

Steps of Anesthesia :

1. Induction : The period of time from the onset of administration of the anesthetic to    the development of effective surgical anesthesia in the patient.
2. Maintenance : A sustained surgical anesthesia
3. Recovery : Time from discontinuation of administration of the anesthesia until consciousness and protective physiologic reflexes are regained.

Desired Effects Of General Anesthesia  (Balanced Anesthesia) :

• Rapid induction 
• Sleep
• Analgesia
• Secretion control
• Muscle relaxation 
• Rapid reversal

Anesthesia Drugs Market :

The anesthesia drugs market research specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol dis odium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015.

Intravenous anesthetic drugs accounted for the largest share –65% – of the U.S. general anesthetics drugs market in 2011.

Major players such as Abbott laboratories (U.S.), Astrazeneca Plc. (U.K.), Baxter International Inc. (U.S.), Bedford Laboratories (U.S.), Bioniche Pharmaceuticals (U.S.), Eisai Co. Ltd. (Japan), Hospira Inc. (U.S.) and JHP Pharmaceuticals (U.S.).

For Detail Report : CLICK HERE

Commercial Airport Lighting Market - Terminal, Airside and Landside from 2013 To 2018

 

Introduction :

The scope of Airport Lighting Market report is to identify the business opportunity that arises from new airports, terminals or any airport expansion/up gradation. The airfield lighting plays a crucial role at airports in order to enhance passenger experience. Airports have begun to install light emitting diodes (LEDs) on runway edge lights and taxiway lights, in hope to increase safety and to reduce the cost of runway operation.

 

An Airfield Lighting Market has three important divisions:

• Majority of lighting solutions are present at Air side.
• Followed by lighting solutions in the land side right from arrival of passengers to airport and right from disembarkation of passengers to exiting the airport.
•  Lastly, the ground access areas that is parking pick up and drop points and so on.

Lighting is an important safety feature which is necessary at every airport to facilitate night flying. In general, the type of aircraft used in the airport, determines the type of lighting solutions necessary. One particular type of required lighting system is an edge-light system which is used to outline usable operating areas of airports during periods of darkness or low visibility. There are several edge-light systems that are currently available.

Among the key landing and ground-movement visual aids are those located in the pavement of runways and taxiways. These lighted aids can be needed for landing, roll-out, take-off, ground movement, traffic control and high-speed exits from runways and apron guidance for docking. Techniques can be constantly developed to make its installation compatible with paving requirements yet without compromising the integrity and function of the lights.

The latest Airport Lighting said to be very advanced and effective solution/systems for air side, land side and ground access. Many designs and modules have been developed by many consultants and the airport has the option to choose which module they can use for their airports.

 

Market Of  Airport Lighting :

 

Markets Covered : 

Airport Lighting Market segments the airport lighting market by:

1. North America,
2. South America,
3. Europe (including Russia),
4. Africa and
5. APAC

 

Stakeholders Of Airport Lighting Market :

1. Light manufacturers
2. Hardware/service and solutions providers
3. Airlines
4. Technology suppliers
5. Airport Lighting consultants
6. Aviation regulating bodies
7.  Airports
8. Passengers  

 Airport Lighting accounts for approximately 25% to 30% of electrical use in most commercial buildings. At airports, this can increase up to 40%. With the addition of Operation and Maintenance, lighting holds the greatest prospective for saving energy at small airport terminals. Retrofits in lighting systems can have significant impact on the other, more costly infrastructure upgrades such as ventilation and boilers equipment owing to reduction in cooling loads provided by more efficient fluorescent fixtures. Lighting upgrades open up power for other systems or expansion of facilities. Airport Lighting improvements, coupled with other energy efficiency projects, eliminated the need to construct a new energy plant. Airport Lighting upgrades also has the potential to improve productivity and passenger experience by improving light quality and levels, improves more control by turning lights off or balancing levels with daylight, and reduce maintenance costs by increasing lamp life.

Lamp Fixtures

Extensive research says that the lamp and fixture retrofits as low-cost energy efficiency improvements that return noteworthy savings. It may also be noted that lighting improvements are one of the most noticeable ways to save energy, which, along with visual display upgrades. Screw-in incandescent fixtures to compact fluorescent lamps (CFL) are some of the change that is happening all over the world, which use up to 75% less energy and last significantly longer. The cost of CFL fixtures has dropped extensively in recent years making this upgrade even more affordable. Maintenance savings may also be found owing to reduced replacement frequency.

Although often distinguished as a high-efficiency lamp, fluorescents can be limited in lighting output comparative to other lamps, specifically high-intensity-discharge or HID. Areas where conversion from fluorescent to HID may be appropriate include exterior precautionary lighting on terminals and areas which can be surrounded by parking structures attached to the terminals.

Central Automated Lighting

Another type of lighting control system involves centralized control of all lighting fixtures within the terminal. By using central control, areas of activity that were not previously monitored and tracked will now be monitored and tracked, and ignored or crisis areas will be identified. In addition, some central controls can track total hours that lamps have been in service, supplying staff on duty with useful information with which they could schedule re-lamping programs. Another strategy that put forth is to plan lighting controls to periodical turning off the lights within a certain area of the building during the off-peak period. Lighting reduction during non-peak hours and utilization of central lighting control is a common practice followed by most of the airports.

According to a new market research report, "Commercial Airport Lighting Market (Terminal, Airside & Landside)(2013 – 2018)", authored by MarketsandMarkets , the total airport lighting market is expected to reach $244.3 Million by 2018 with a CAGR of 6.07%. 

For Detail Report : http://www.marketsandmarkets.com/Market-Reports/airport-lighting-market-1060.html

 

Molecular Diagnostics Market : Trends , Opportunities and Market Forecasts

Introduction :

Molecular diagnostic detects a specific sequence in DNA or RNA that may be associated with disease,also includes SNP,insertions,deletions,rearrangements and others.

 

 Application can be Found in Following Areas:

1. Infectious diseases
2. Oncology
3. Pharmacogenomics
4. Genetic disease screening
5. Human leukocyte antigen typing
6. Coagulation

 

In Molecular Diagnostic each molecule requires following three steps :

1. The extraction and purification of nucleic acid.
2. The amplification or making copies of the nucleic acid of interest (target) or attaching multiple copies of a dye to a   single target copy.
3. The detection of the amplified target using real time polymerase chain reaction (PCR) or end product detection including   microarrays, Luminex (similar to flow cytometry), or sequencing.

These three steps can be performed by three separate devices or combined into one device .

 

The Primary goal of Molecular Diagnostics :

• To introduce essential concepts in  molecular diagnostics that impact on the identification of novel markers of human diseases

• To develop and apply useful molecular assays to monitor disease, determine appropriate treatment strategies, and predict disease outcomes.

Following Image Demonstrate Molecular Diagnostics :

 Source : http://www.cancer.gov

Molecular Diagnostics Market  

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms, help determine a specific therapy, or risk of developing a specific disease, or other health conditions. MDx is the fastest growing segment within the in-vitro diagnostic (IVD) space, driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost-effective testing.

Owing to these factors, The molecular diagnostics market crossed $4.8 billion in 2011, and is poised to grow at a CAGR of 9.1% in the next five years.

MDx involves instruments and reagents that leverage multiple technologies to identify genetic variations. The technologies utilized in molecular diagnostics include polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization (In-situ Hybridization & fluorescence in situ hybridization (FISH)), DNA Sequencing, next generation sequencing (NGS), micro arrays, and others.

Molecular diagnostics has applications in infectious disease molecular testing, oncology, blood screening, genetic testing, DNA fingerprinting (e.g., paternity testing, forensic testing), microbiology, tissue typing, and food pathogen detection testing. The booming MDx areas are molecular tests for women’s health, oncology, and organ transplant testing.

Global Molecular Diagnostics Market Revenue, By Technology, 2010 - 2017 ($Million)

Source : http://www.marketsandmarkets.com

North America dominated the molecular diagnostics market in 2011; the U.S. is the prime market for molecular diagnostics companies due to the availability of government funds, rising incidence of chronic diseases related to the aging population, and high awareness of pharmacogenomics/personalized medicine. In addition, major local companies have easy access to this market, which makes the U.S. the largest and most significant market for suppliers. Europe is still suffering from the economic downturn and the Eurozone crisis and it is predicted that customers will delay purchases of capital equipments; this is expected to hamper the growth of this market, albeit for a short term. The Asian market, however, shows greater opportunities with the highest CAGR due to increased purchasing power, an emerging mindset toward wellness, preventive medicine, and increased access to cutting-edge products and services.

Factors like increase in awareness and acceptance of personalized medicine, advancements in molecular techniques, and increasing investments in genomics & proteomics research will spur the molecular diagnostics market in the future. Yet, reimbursement issues for non-coded tests and complex regulatory framework will restrict the growth of this market.

Molecular diagnostic tools have a vast base of end-users, which includes hospital-based laboratories, reference laboratories, and others (physicians’ labs, research laboratories, other healthcare clinics, and government agencies). Hospitals offer the major chunk of business for MDx companies; however, reference laboratories are growing at a high CAGR and are driving the market, as they perform complex tests and offer expertise to small hospitals setups, clinical researchers, and insurance companies.

Although the market for molecular diagnostics is fragmented with more than 500 companies, the most prominent players are Roche Diagnostics (Switzerland), Novartis (Switzerland), Gen-Probe (U.S.), Qiagen (The Netherlands), Abbott Diagnostics (U.S.), Becton Dickinson (U.S.) and Cepheid (U.S.), to name a few.

For Complete Market Research Report On Molecular Diagnostics Market : http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

Global Ultrasound Devices Market statistics and forecast by 2017

The medical ultrasound devices market consists of devices that involve the projection of cyclic sound waves ranging between 20 KHz – 10 MHz. These waves create varying pressures on biological tissues, based on the level of frequencies used. Ultrasound has the ability to raise the temperature of a substance when directed in focused waves, and thus also finds therapeutic applications.

 

source:http://www.nydnrehab.com 

Medical application of ultrasound began post World War II in the 1940s, with the first diagnostic application being in cardiology and brain tumor identification. Today ultrasound has medical applications in every area of the body and gives accurate results regarding overall structural composition, based on the density and transmission of the sound waves through biological tissue. Along with the conventional black and white ultrasound imaging systems, the global market also has high potential for color Doppler and 3D/4D imaging systems. The imaging clarity and diagnostic abilities offered by recent ultrasound devices is predicted to give a thrust to the overall global diagnostic market; this will also support other imaging technologies such as Magnetic Resonance Imaging, Computed Tomography, and PET/SPECT.

Ultrasound frequencies ranging between 0.8 MHz - 3.3 MHz have found use in therapeutic application in ablation of tissue. The ultrasound energy focused and directed towards unwanted tissue is transmitted harmlessly through the upper layers of tissue and focused only on the target area. This raises the temperature of the tissue, as a large amount of sonic energy is deposited within. As living cells are not able to dissipate the heat created quickly enough, the temperature rises above the survival threshold and the cells finally die due to coagulation necrosis. Cell death is also caused by cavitation, which is the implosion of microscopic bubbles inside the cell, thus leading to destruction of the cellular wall.

The diagnostic and therapeutic ultrasound segments consist of highly advanced technologies used for imaging and treating a variety of medical conditions. The ultrasound imaging modality is a harmless non-invasive technique. There are no side-effects associated with its use, as researched in the past few years. Obstetrics and gynecology is the most popular application for ultrasound imaging; it has popularized ultrasound greatly and is one of the reasons people are familiar with the technology.

Although the current market is dominated by 2D, 3D & 4D ultrasound market is highly technologically driven, competitive and poised to become significant in size. The global market is driven by increasing application areas in oncology, cardiology and emergency medicine. The diagnostic market accounts for a much larger share since the technology is more mature than newly developed technologies such as HIFU.

Ultrasound also has other applications in movement detection for security, structural integrity of constructions, detection of wielding cracks, navigation and ranging in military and astronomy.

The 2011 global market is estimated to be at $5.6 billion and is predicted to grow at a CAGR of 6.2% to reach $8.1 billion by 2017.  Cart-based systems command the largest share of the ultrasound systems and are predicted to remain so for the coming decade. Devices such as Vscan (GE Healthcare), Acuson p10 (Siemens) and by other niche players such as Mobisante (U.S.) are expected to propel the growth of the hand-held segment of ultrasound devices. Meanwhile, the market such as High Intensity Focused Ultrasound (HIFU) and lithotripters is driven by the increasing demand from changing trends in fields such as cosmetology, ablative procedures, and lithography applications in kidney stones, bladder stones and others.

The global diagnostic market is led by key market players such as GE Healthcare (U.K.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Esaote Group (Italy), Toshiba Medical Systems Corporation (Japan), HITACHI-Aloka Medical Corporation (Japan), SonoSite, Inc. (U.S.), Misonix, Inc. (U.S.), Ultrasonix Medical Corporation (Canada), Zonare Medical Systems (U.S.), and other players such as Mindray Medical (China), Terason Corporation (U.S.), Verathon, Inc. (Canada), Supersonic Imagine (France), Analogic Corporation (U.S.), and TomTec Imaging Systems GMBH (Germany).

The global therapeutic market is led by companies such as EDAP TMS (France), Dornier Medtech (Germany), InSightec (U.S.), Siemens Healthcare (Germany), Philips Healthcare (The Netherlands), and Misonix, Inc. (U.S.).

For Detail Report :http://www.marketsandmarkets.com/Market-Reports/ultrasound-market-467.html

Oral Care Product Market From 2011 To 2016

Introduction :

Oral Care products consists of :

• Bio-material Products
• Prostheses product
• Endo Product
• Or-tho Product
• Periodontics Product
• Restorative Product
• Alloys Product
• Cements Product
• Bonding Agent Product
• Various  Impression Materials
• Various  Preventives
• Various  Disposables

Oral Care Market consist of all these products.And no doubt it is very Huge market Money Wise.As we Are speaking about money let me tell you global market for all above products was valued $13 billion in 2011 and it is Expected to grow at CAGR (Compound Annual Growth Rate) of 6% from 2011 to 2016,which is quite good.

 

Market of Oral Care Products :

the major reason for this growth is the increasing age of population across the globe along with this another factor is demand for enhanced oral care offers huge opportunities for innovation in products.in this market most product providers believe in direct customer interaction to improve sales and increase awareness of their products.Speaking about Developing nation the oral product market growing like anything the basic reasons behind it is increased awareness about oral hygiene,rising income level of masses in countries like India,China and finally new product development boots the market for dental products.similarly rising demand for aesthetic density and growing dental tourism further ensures growth of this market in upcoming years.

Emerging technology will have a great impact over the overall growth of the market as these technology will reduce the turnaround time for dental procedures and also improve the efficiency.foe example CAD/CAM technology has reduced designing time for dental prostheses significantly,3D imaging technology have improved patient diagnosis and procedure planning.
so we can say because of these technology oral care product market is growing in very fast rate.

If we speak about this market according to the region prospective we can say Europe is the largest regional market for dental products.we can say this because numerous market leaders based in this region and secondly large percentage of population can afford expensive dental procedures.America is the largest share holder of this market in Europe.Speaking about Asian countries like India , china , south Korea , Malaysia , Thailand and Singapore are also major contribute of this market the reason behind it is the population and increasing per capita incomes of large middle class population.

 

Major Player Of Oral Care Product Market Include :

1. Dents ply International (U.S.)
2. Ivoclar Viva-dent (Liechtenstein)
3. Dana her Corporation (U.S.)
4. Heraeus Dental (Germany)
5. 3M-ESPE (U.S.)
6. GC Corporation (Japan)

 For Detail Report On Oral Care Product Market : http://www.marketsandmarkets.com/Market-Reports/oral-care-products-dental-consumables-market-699.html

HEALTHCARE INFORMATION TECHNOLOGY : -INTRODUCTION,BENEFITS,MARKET

INTRODUCTION

Healthcare information technology is one of the area in IT Which is totally focused on Heathcare industry.In resent Days IT is emerged as a very profitable solution for Healthcare industry.It has helped to improve quality, safety and efficiency of healthcare delivery by Designing, developing, Creating and maintaining the information system in a very cost effective manner. 

Various Automated and inter-operable healthcare information systems are low in cost but provide improved efficiency and less errors along with that provide better consumer care and services. Similarly it helps healthcare providers to collect, store, retrieve and transfer information electronically. 

Following are some major and consistent utilization of HIT:

1. Reduction of healthcare cost.
2. Improved and efficient healthcare services.
3. Increased and efficient healthcare productivity.
4. Prevent human errors, increased accuracy and procedural correctness.
5. Efficient administrative and healthcare work processes.
6. Vastly reduced paperwork and idle work time.
7. Improved and effective communication about health informatics among healthcare professionals.
8. Affordable healthcare.

Along with improved individual patient care, it will bring many public benefits, Such as:

1. Improved tracking of chronic disease management.
2. Early detection of infectious diseases.

Market of healthcare Information Technology

Due to all these benefits of HIT there is consistent rise in adoption of healthcare IT in Healthcare industry.

There are two Major segments of Healthcare IT :

1. Providers
2. Payers

The provider provide Various applications of clinical information system such as EHR,CVIS,CDSS, PACS, RIS, and CPOE to payers.HIT is the fastest growing market and highest revenue generated from above applications. Integrated EHR(electronic health record) is central component of the healthcare IT Infrastructure because it is fastest growing segment due to incentives offered to U.S. physicians who successfully meet the criteria of 'Meaningful Use' by 2015 and financial support provided by the HIPPA act.along with this various initiatives have been taken governments across the world to increase the adoption of EHR.

Following are the effective Government initiatives for adoption of EHR:-

1. the Pay-for-Performance program
2. the Minnesota EHR Incentive Program
3. the Health Information Technology Services Nova Scotia Program
4. the Alberta Net care EHR Program
5. e-health Ontario is an effective initiative

The another major segment in HIT is Cloud computing,it is emerged as a silver-lining model in HIT.

Following are the major pulse points about Cloud computing in HIT:-

1. management and migration of huge amount of data.
2. Cost Efficient.
3. anytime access from multiple mobile devices.
4.  high availability for large backup data storage.
5. Easy to use

There are  private cloud, public cloud, and hybrid cloud among these for HIT the best suited and HIPAA recommended cloud is public cloud.

The provider IT is further segmented into two that are:-

1. Clinical IT applications
2. Non-clinical IT applications 

Clinical IT applications includes:-

1. Hospital informatics :-EHR, PACS, CPOE, RIS, CDSS, and CVIS
2. Pharmacy informatics
3. Laboratory informatics

Non-clinical IT applications includes:-

1. Payroll
2. Patient billing
3. Revenue cycle management
4. Cost accounting
5. Others

HIT payer Segmented into :-

1. workflow
2. administrative 
3. other solutions

Key Market Player Of HIT:-

1. Cerner Corporation
2. Epic 
3. Carestream Health
4. Inc. 
5. McKesson Corporation 
6. Athenahealth, Inc. 
7. Siemens Healthcare 
8. Medical Information System, Inc.
9. Allscripts Healthcare Solutions, Inc.
10. GE Healthcare 
11. Agfa Healthcare
12. NextGen Healthcare Information System
13. LLC
14. Novarad Corporation 
15. Philips Healthcare 
16. Hewlett-Packard

According to markesandmarkets market research report the global HIT market is estimated to grow at a CAGR of 7.0% to reach $56.7 billion by 2017 from $40.4 billion in 2012 due to the significant demand for clinical information technology, administrative solutions, and services.

For More Details :-  http://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Pharmacogenomics And Pharmacogenomics Market By 2017

The basic aim of Pharmacogenomics is to develop a relation between drug therapy and genetic structure of human which helps to optimize drug therapy with respect to patients genetic structure to maximize efficacy and minimize side effects.

so sometimes it is referred as "Personalized Medicine".

we can define it as :

Pharmacogenomics is the technology that analyses how Drug responses to an individual according to their genetic structure.

It analyse the influence of genetic variation of individual to the drug response by correlating gene expression (the process which is used in synthesis of various functions on the basis of gene information ) or  single nucleotide  polymorphism with drug toxicity or efficacy.

Basically variations in genetic structure,lifestyle of individual,environmental conditions of particular region,severity and type of disease affect on the treatment by individual basis.So genetic tests assists to determine best possible deug therapies and treatment protocol.

there are two types of input can be used to provide pharmacogenomics based on recommendation for a given drug that are 

1. Genotyping :  It is the process which determine the differences in the genetic structure of an individual's DNA sequence by comparing it with the reference sequence.
2. genome sequencing : It is the symbolic linear depiction of organism's hereditary information.  

Basic Goals of pharmacogenomics 

1. Focus On prevention not on reactions
2. Enhance safety of drugs
3. optimize Drug Therapy
4. Improve compliance of patient
5. Reduce Cost of healthcare

Applications:

1. Pharmacogenomics has applications in various diseases like Cancer,depression,HIV,tuberculosis,asthma,diabetes,cardiovascular disorder,etc
2. in cancer treatment these tests are used to identify which patients give best responce to which treatments.
3. pharmacogenomic tests provide various tools for physicians better management of medicine and there side effects on individual basis.
4. pharmacogenomic is also known as Companion diagnostics means tests are bundled with various drugs.
5. Beside efficacy,pharmacogenetics can help to identify toxicities of drug.

Global Market Of Pharmacogenomics:

source: marketsandmarkets.com

The global bioinformatics market has value at about $2.9 billion in 2012 and will reach to $7.5 billion by 2017 at a CAGR of 20.9%. These technologies are used in various pharmaceutical and biotechnology sectors to support their growth. Major sectors which are influenced by this technology are medicine, agriculture, environment, animal, forensic, academics,etc. 

For More info CLICK HERE

Major Market Barriers:

1. FDA Approval process for Pharmacogenomics is very slow process
2. Complexity of Technology
3. Need More R&D
4. Development Cost is high 

Conclusion:

Best way to explain importance of Pharmacogenomics is: 

“It’s far more important to know what person the disease has than what disease the person has.” -Hippocrates

And speaking about the Pharmacogenomics market,right now the market is in the R&D process but speaking about future it will be a multi billion market.

For Market Forecast you can also see Market report on Pharmacogenomics Market- http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html